HDB Financials IPO 2025 largest NBFC 12500 CR Issuance Price HDFC Bank Retail Section has been pre-ordered
HDB Financial Services IPO: The largest public offering in India’s non-bank financial company (NBFC) in 2025, with its last lap being the last one as it closes today on June 27.
HDB Financial, supported by HDFC Bank, lists a combination of Rs 250 billion and Rs 100,000 billion through an offer for sale (OFS). To date, the overall subscription does not mean that the retail segment is fully subscribed; until Friday morning, it had revenues of less than 76%, providing investors with a last chance.
Why is this IPO important
The IPO is not only a fundraising event, but also part of the Reserve Bank of India directive “upper” NBFC to be listed under the regulations of scale. HDB Financial is one of the largest retail price-centric NBFCs with a total loan of Rs 1.06 crore, as well as a diversified book on corporate loans, asset financing and consumer financing.
strategy
All analysts take HDB’s long-term growth path, their HDFC banking legacy, strong credit underwriting and an extensive distribution network. Sharekhan believes that given its better governance and higher growth track, IPO pricing is 3.2 to 3.4 times compared to peers like Bajaj Finance and Chola.
Medium-term risk
Despite a decline in net interest margins in fiscal 25 and a slight increase in credit costs, brokers such as Chola Securities will inflate in the short term, with lower interest rates cycles and normal monsoons. SBI Securities raised similar concerns but released a “subscribe” rating based on strong governance and high brand recalls.
Where will IPO money flow
Rs 250 crore collected through the new problem will be used to increase the level of capital in HDB, thereby achieving future growth in lending. On the other hand, OFS components will allow HDFC banks to unlock value without compromising regulatory requirements.
Should investors buy it?
HDB Financial’s IPO could be an attractive bet for retail investors seeking exposure to India’s formal credit boom and long-term NBFC expansion. Despite macro headwinds, the fundamentals of the company, brand strength and capital adequacy plans can justify patients’ long-term investment views.
